Infect Chemother.
2009 Oct;41(5):259-264. 10.3947/ic.2009.41.5.259.
Vaccine Strategy for Influenza A (H1N1) Pandemic
- Affiliations
-
- 1Division of Infectious Disease, Department of Internal Medicine, Korea University School of Medicine, Seoul, Korea. wjkim@korea.ac.kr
- KMID: 1473650
- DOI: http://doi.org/10.3947/ic.2009.41.5.259
Abstract
- Four months have passed since the World Health Organization declared worldwide pandemic by the novel influenza A (H1N1) virus, but the incidence rate does not seem to dwindle and each day we are faced with news from all around the world on death by this troublesome virus. Pandemic influenza vaccine is considered one of the most effective countermeasures for protecting susceptible individuals. However, it is envisaged that production of sufficient vaccine within an ideal timeframe will not be feasible, and thus, vaccine supply is expected to fall short of demand. Therefore, it is mandatory to establish a proper vaccine strategy for maximizing the effect of pandemic influenza vaccine. In this article, we have described many critical points that should be taken into consideration when establishing pandemic vaccine strategies based on the newest data and the strategies adopted by other countries.
